Cubist Systematic Strategies’s Keros Therapeutics KROS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-198,411
| Closed | -$2.02M | – | 1971 |
|
|
2025
Q1 | $2.02M | Buy |
198,411
+197,201
| +16,298% | +$2.01M | 0.01% | 686 |
|
|
2024
Q4 | $19.2K | Buy |
+1,210
| New | +$19.2K | ﹤0.01% | 1378 |
|
|
2024
Q1 | – | Sell |
-411
| Closed | -$16.3K | – | 2542 |
|
|
2023
Q4 | $16.3K | Buy |
+411
| New | +$16.3K | ﹤0.01% | 1947 |
|
|
2023
Q2 | – | Sell |
-8,306
| Closed | -$355K | – | 2664 |
|
|
2023
Q1 | $355K | Buy |
8,306
+3,844
| +86% | +$164K | ﹤0.01% | 1948 |
|
|
2022
Q4 | $214K | Buy |
4,462
+4,167
| +1,413% | +$200K | ﹤0.01% | 2615 |
|
|
2022
Q3 | $11K | Sell |
295
-24,051
| -99% | -$897K | ﹤0.01% | 3479 |
|
|
2022
Q2 | $673K | Buy |
+24,346
| New | +$673K | ﹤0.01% | 2400 |
|
|
2022
Q1 | – | Sell |
-214
| Closed | -$13K | – | 3645 |
|
|
2021
Q4 | $13K | Sell |
214
-4,758
| -96% | -$289K | ﹤0.01% | 3392 |
|
|
2021
Q3 | $197K | Buy |
+4,972
| New | +$197K | ﹤0.01% | 2590 |
|
|
2021
Q2 | – | Sell |
-100
| Closed | -$6K | – | 3000 |
|
|
2021
Q1 | $6K | Sell |
100
-100
| -50% | -$6K | ﹤0.01% | 2787 |
|
|
2020
Q4 | $14K | Sell |
200
-707
| -78% | -$49.5K | ﹤0.01% | 2511 |
|
|
2020
Q3 | $35K | Buy |
907
+9
| +1% | +$347 | ﹤0.01% | 2385 |
|
|
2020
Q2 | $34K | Buy |
+898
| New | +$34K | ﹤0.01% | 2292 |
|